BRCA1 and ovarian carcinoma: No studies are available on the influence of hormonal contraceptives on the risk of local recurrence or distant metastases for breast cancer in BRCA1/2-pV carriers or carriers with pV in breast and/or ovarian cancer genes other than BRCA1 and BRCA2. The approach should be the same as for women with breast cancer from the general population.